Paul Glazer

Title: The Innovative Contributions of Paul Glazer

Introduction

Paul Glazer is a notable inventor based in Chestnut Hill, MA (US). He has made significant strides in the field of ophthalmology, particularly with his work on intraocular lenses. His innovative approach has the potential to enhance vision correction for individuals with various eye conditions.

Latest Patents

Glazer holds a patent for "Injectable physiologically adaptive intraocular lenses (IOL's)." This invention discloses a device and method for forming an adaptive optic within the capsule of a human eye. The device features a capsular interface that encloses an optically acceptable medium, establishing a physiologic range of optical power in response to varying ciliary contractile states. The preferred bi-phasic medium consists of a solid three-dimensional polymeric network suspended in a liquid aqueous phase, which is bonded to the capsular interface. This polymeric network not only provides shape to the capsular interface but also offers optical power and a physiologic response to the suspensory ligament. The three-dimensional network mimics the stacked fiber configuration and elasticity of a natural lens. An alternative embodiment utilizing a single-phase medium is also disclosed, featuring associated structural elements within the capsular interface.

Career Highlights

Glazer's career is marked by his dedication to advancing medical technology. His work at Adaptilens, LLC has positioned him as a key player in the development of innovative solutions for vision correction. His patent reflects his commitment to improving patient outcomes through cutting-edge technology.

Collaborations

Throughout his career, Glazer has collaborated with talented individuals such as Liane Clamen and Michael T Milbocker. These partnerships have contributed to the success of his projects and the advancement of his inventions.

Conclusion

Paul Glazer's contributions to the field of ophthalmology through his innovative patent for injectable physiologically adaptive intraocular lenses demonstrate his commitment to enhancing vision correction technology. His work continues to pave the way for future advancements in eye care.